Home > News > Techniques for Rapid Drug Discovery Now Focusing on Nanoscience Research
May 3rd, 2007
Techniques for Rapid Drug Discovery Now Focusing on Nanoscience Research
Ron Zuckermann, lead scientist for Lawrence Berkeley National Lab's Molecular Foundry Biological Nanostructures Facility, is taking the same techniques drug companies use to discover drugs to help nanoscientists cut the cost and shorten the time for their hunt for useful nano-compounds.
Dr. Zuckermann knows a lot about that proven drug-discovery process, dubbed combinatorial chemistry - he helped invent the process more than a decade ago. Before coming to the Molecular Foundry, Dr. Zuckermann worked for the biotechnology industry, and was one of the creators of the combinatorial chemistry techniques, whereby researchers create and test thousands (and in some cases millions) of compounds for just the right properties. His current LBNL work is sponsored by the Department of Energy, and is available for universities and private research arms to participate in.
Rice physicist emerges as leader in quantum materials research: Nevidomskyy wins both NSF CAREER Award and Cottrell Scholar Award August 20th, 2014
Promising Ferroelectric Materials Suffer From Unexpected Electric Polarizations: Brookhaven Lab scientists find surprising locked charge polarizations that impede performance in next-gen materials that could otherwise revolutionize data-driven devices August 18th, 2014
Nano Bonds Increase Raw Strength of Fireproof Concretes August 18th, 2014
Molecular engineers record an electron's quantum behavior August 14th, 2014
Sunblock poses potential hazard to sea life August 20th, 2014
Newly-Developed Nanobiosensor Quickly Diagnoses Cancer August 20th, 2014
Ultrasonic Waves Applied in Production of Graphene Nanosheets August 20th, 2014
The channel that relaxes DNA: Relaxing DNA strands by using nano-channels: Instructions for use August 20th, 2014